Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-01-03
2006-01-03
Spivack, Phyllis G. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S252130, C514S254040, C514S320000
Reexamination Certificate
active
06982262
ABSTRACT:
The present invention relates to the combination of cyamemazine and an atypical neuroleptic, or a pharmaceutically acceptable salt thereof, and to the use thereof in the treatment of schizophrenia, and in particular of acute episodes of schizophrenia.
REFERENCES:
patent: 4804663 (1989-02-01), Kennis et al.
patent: 4831031 (1989-05-01), Lowe et al.
patent: 5229382 (1993-07-01), Chakrabarti et al.
patent: 6150353 (2000-11-01), Broekkamp et al.
patent: 0196132 (1986-10-01), None
patent: 0200322 (1986-11-01), None
patent: 0392959 (1990-10-01), None
patent: 0454436 (1991-10-01), None
patent: 0529500 (1992-08-01), None
patent: 0586191 (1994-03-01), None
patent: 0733634 (1996-09-01), None
patent: 2722099 (1996-01-01), None
patent: WO 94/25460 (1994-11-01), None
patent: WO 96/30375 (1996-10-01), None
patent: WO 98/43646 (1998-10-01), None
patent: WO 99/16313 (1999-04-01), None
Dietch, James T. et al., Aggressive Dyscontrol in Patients Treated with Benzodiazepines, J. Clin Psychiatry (1988, pp. 184-188, vol. 49:5).
Overall, John E. et al., The Brief Psychiatric Rating Scale, Psychological Reports, (1962, pp. 799-812, vol. 10).
Senninger, J. L. et al., La Risperidone Dans Le Traitement de L'Agressivite Des Schizophrenes, Ann. Med. Psychol. (1998, pp. 210-213, vol. 156 No. 3).
Stimmel, Glen L., Benzodiazepines in Schizophrenia, Supplement to Pharmcotherapy (1996, pp. 148-151, vol. 16).
Vandel, et al, Drug extrapyramidal side effects, Eur. J. Clin. Pharmacol. (1999, pp. 659-665, vol. 55, No. 9).
Warneke, Lorne B., Benzodiazepines: Abuse and New Use, Can. J. Psychiatry (1991, pp. 194-205, vol. 36).
Wolkowitz, Owen M. et al., Benzodiazepines in the Treatment of Schizophrenia; A Review and Reappraisal, Am J Psychiatry (1991), pp. 714-726, vol. 148:6).
Zini, R et al., The Influence of Various Drugs on the Binding of Tianeptine to Human Plasma Proteins, International Journal of Clinical Pharmacology, Therapy and Toxicology (1991, pp. 64-66, vol. 29 No. 2).
Dib Michel
Leperlier Cyrille
Aventis Pharma S. A.
Gupta Balaram
Spivack Phyllis G.
LandOfFree
Combination of cyamemazine and an atypical neuroleptic does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination of cyamemazine and an atypical neuroleptic, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination of cyamemazine and an atypical neuroleptic will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3528939